Zealand Pharma Feed

Land	Danmark
Lista	Mid Cap Copenhagen
Sektor	Hälsovård
Industri	Bioteknik

2020-02-27 08:00:00 Zealand Pharma to attend Credit Suisse 2020 Global Healthcare Conference -7,31% | 69,3 MDKK

2020-02-26 09:14:42 Zealand Pharma hosts conference call on March 12 at 4 pm CET (10 am EST) to present full year results for 2019 -0,38% | 82,7 MDKK

2020-02-20 19:30:00 Zealand Pharma to attend 9th Annual SVB Leerink Global Healthcare Conference -1,48% | 47,6 MDKK

2020-02-11 13:35:00 Zealand Pharma major shareholder announcement: Wellington Management Group LLP +3,96% | 31,5 MDKK

2020-02-10 02:40:00 Zealand Pharma announces bid to acquire Valeritas +0,31% | 21,6 MDKK

2019-12-31 18:00:00 Total number of shares and voting rights in Zealand Pharma at December 31, 2019 -2,38% | 37,9 MDKK

2019-12-13 15:30:00 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons +0,76% | 36,5 MDKK

2019-12-13 15:00:00 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants +0,76% | 36,5 MDKK

2019-12-11 12:30:00 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants -2,98% | 30,3 MDKK

2019-12-10 18:00:00 Financial calendar for Zealand Pharma in 2020 -2,98% | 30,3 MDKK

2019-12-10 08:00:00 Zealand Pharma partner Beta Bionics receives FDA Breakthrough Device Designation for the iLet™ Bionic Pancreas System +6,13% | 56,0 MDKK

2019-12-05 17:16:28 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons +0,57% | 27,9 MDKK

2019-12-05 11:00:00 Zealand Pharma grants new warrants under the employee warrant program -4,73% | 48,7 MDKK

2019-12-04 14:55:19 Zealand Pharma initiates second Phase 3 trial with dasiglucagon for the treatment of congenital hyperinsulinism +7,95% | 65,5 MDKK

2019-11-29 18:00:00 Total number of shares and voting rights in Zealand Pharma at November 30, 2019 -2,97% | 27,8 MDKK

2019-11-27 15:05:00 Notification of managers and closely related parties’ transactions with Zealand Pharma shares in connection with employee warrant program -0,66% | 30,2 MDKK

2019-11-22 13:00:00 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants +2,49% | 44,2 MDKK

2019-11-14 15:00:00 Zealand Pharma completes Phase 3 clinical program for HypoPal® rescue pen, initiates a new Phase 2 clinical proof of concept trial with dasiglucagon, and secures DKK 560 million in additional investment +4,94% | 88,0 MDKK

2019-10-28 17:00:00 Zealand Pharma hosts conference call on November 14 at 4 PM CET (10 AM ET) to present third quarter results for 2019 +0,49% | 21,7 MDKK

2019-10-22 12:05:00 Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics +4,23% | 32,8 MDKK

2019-09-30 17:00:00 Total number of shares and voting rights in Zealand Pharma at September 30, 2019 -4,87% | 24,7 MDKK

2019-09-24 11:57:25 Zealand Pharma achieves primary and all key secondary endpoints in pediatric Phase 3 trial with dasiglucagon for severe hypoglycemia +6,79% | 92,8 MDKK

2019-09-13 12:32:08 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants +1,12% | 18,3 MDKK

2019-09-11 10:30:00 Zealand Pharma completes subscription of new shares and registration of capital increase +0,88% | 26,0 MDKK

2019-09-10 22:30:00 Update regarding registration of new shares for Zealand Pharma +0,88% | 26,0 MDKK

2019-09-05 23:30:00 Zealand Pharma major shareholder announcement: Van Herk Investments -0,06% | 42,6 MDKK

2019-09-05 08:00:00 Zealand Pharma announces private placement and directed issue of new shares with expected gross proceeds of DKK 559.6 million +7,89% | 66,6 MDKK

2019-09-03 08:00:00 Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes +9,22% | 38,8 MDKK

2019-08-30 16:00:00 Total number of shares and voting rights in Zealand Pharma at August 31, 2019 +1,65% | 19,9 MDKK

2019-08-29 16:00:00 Zealand Pharma to attend Morgan Stanley 17th Annual Global Healthcare Conference -1,55% | 14,4 MDKK

2019-08-28 11:00:00 Correction: Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer -1,90% | 17,5 MDKK

2019-08-28 08:00:00 Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer -1,90% | 17,5 MDKK

2019-08-27 10:00:00 Zealand Pharma relocates headquarters to accommodate growth -2,22% | 23,5 MDKK

2019-08-23 13:02:17 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants +1,30% | 13,7 MDKK

2019-08-15 15:00:00 Zealand Pharma delivers strong clinical results during the first half of 2019 and accelerates commercial build-up in the U.S. -2,22% | 34,1 MDKK

2019-08-01 17:00:00 Zealand Pharma hosts conference call on August 15 at 4 pm CET (10 am EST) to present first half results for 2019 -1,77% | 11,0 MDKK

2019-07-29 11:00:00 Zealand Pharma announces change in corporate management +0,84% | 19,7 MDKK

2019-06-28 16:00:00 Total number of shares and voting rights in Zealand Pharma at June 30, 2019 +1,71% | 17,9 MDKK

2019-06-26 08:00:00 Zealand Pharma doses first subject in Phase 1 clinical trial with potential next generation dual-acting peptide therapeutic for short bowel syndrome +0,79% | 14,0 MDKK

2019-06-21 09:00:00 Zealand Pharma introduces new website to support people living with short bowel syndrome -1,87% | 10,5 MDKK

2019-06-14 11:00:00 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants +0,28% | 17,1 MDKK

2019-06-13 20:20:22 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants +0,28% | 17,1 MDKK

2019-06-13 10:07:53 Zealand Pharma implements a new long-term incentive program and grants new warrants under the employee warrant program +2,09% | 17,0 MDKK

2019-06-11 02:00:00 Zealand Pharma presents dasiglucagon pivotal Phase 3 trial data at the 79th Scientific Sessions of the American Diabetes Association (ADA) +2,32% | 22,5 MDKK

2019-06-06 08:00:00 Beta Bionics and Zealand Pharma announce superior glycemic control in Phase 2 home-use clinical trial testing the iLet™ bionic pancreas using dasiglucagion +1,98% | 15,8 MDKK

2019-06-04 16:00:00 Zealand Pharma to attend Citi European Healthcare Conference +0,77% | 18,7 MDKK

2019-06-03 17:04:47 Total number of shares and voting rights in Zealand Pharma as of May 31, 2019 +0,77% | 18,7 MDKK

2019-05-28 20:10:37 Correction: Zealand Pharma increases its share capital as a consequence of exercise of employee warrants -2,42% | 12,1 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2020-11-12	Kvartalsrapport 2020-Q3
2020-08-13	Kvartalsrapport 2020-Q2
2020-05-14	Kvartalsrapport 2020-Q1
2020-04-02	Årsstämma 2019
2020-03-12	Bokslutskommuniké 2019
2019-11-14	Kvartalsrapport 2019-Q3
2019-08-15	Kvartalsrapport 2019-Q2
2019-05-16	Kvartalsrapport 2019-Q1
2019-04-05	Ordinarie utdelning ZEAL 0.00 DKK
2019-04-04	Årsstämma 2018
2019-03-07	Bokslutskommuniké 2018
2018-11-15	Kvartalsrapport 2018-Q3
2018-08-16	Kvartalsrapport 2018-Q2
2018-05-16	Kvartalsrapport 2018-Q1
2018-04-20	Ordinarie utdelning ZEAL 0.00 DKK
2018-04-19	Årsstämma 2017
2018-03-07	Bokslutskommuniké 2017
2017-11-08	Kvartalsrapport 2017-Q3
2017-08-24	Kvartalsrapport 2017-Q2
2017-05-17	Kvartalsrapport 2017-Q1
2017-04-06	Ordinarie utdelning ZEAL 0.00 DKK
2017-04-05	Årsstämma 2016
2017-03-15	Bokslutskommuniké 2016
2016-11-09	Kvartalsrapport 2016-Q3
2016-08-25	Kvartalsrapport 2016-Q2
2016-05-18	Kvartalsrapport 2016-Q1
2016-04-20	Ordinarie utdelning ZEAL 0.00 DKK
2016-04-19	Årsstämma 2015
2016-03-16	Bokslutskommuniké 2015
2015-11-05	Kvartalsrapport 2015-Q3
2015-08-28	Kvartalsrapport 2015-Q2
2015-05-22	Kvartalsrapport 2015-Q1
2015-04-22	Ordinarie utdelning ZEAL 0.00 DKK
2015-04-21	Årsstämma 2014
2015-03-12	Bokslutskommuniké 2014
2014-03-21	Ordinarie utdelning ZEAL 0.00 DKK
2013-04-30	Ordinarie utdelning ZEAL 0.00 DKK
2012-04-26	Ordinarie utdelning ZEAL 0.00 DKK
2012-04-25	Årsstämma 2011
2011-04-29	Ordinarie utdelning

Zealand Pharma

Beskrivning

Kalender

Zealand Pharma

Beskrivning

Kalender

Språk

Typ

År

Språk

Typ

Ett Mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden